Apixaban

INTEGRIN LIFE SCIENCES PVT. LTD. offers wide range APIs and Intermediates which includes Drotaverine Hydrochloride. Contact us for more information.

INTEGRIN LIFE SCIENCES PVT. LTD. offers wide range of Intermediates which includes Formamidine acetate (Organic Buiding Blocks Intermediate). Contact us for more information.

INTEGRIN LIFE SCIENCES PVT. LTD. offers wide range of Intermediates which includes L (+) Diethyl Tartrate (Dexlansoprazole Intermediate). Contact us for more information.

INTEGRIN LIFE SCIENCES PVT. LTD. offers wide range APIs and Intermediates which includes Sparfloxacin. Contact us for more information.

INTEGRIN LIFE SCIENCES PVT. LTD. offers wide range of Intermediates which includes Vanadyl acetylacetonate (Lansoprazole Oxidation Catalyst). Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes albuterol / salbutanol sulphate. Therapeutic segment: Anti- asthmatic. Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes aripiprazole. Therapeutic segment: CNS. Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes ciprofloxacin base. Therapeutic segment: Fluoroquinolones. Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes ciprofloxacin hydrochloride. Therapeutic segment: Fluoroquinolones. Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes Dabigatran . Therapeutic segment:  Anticoagulant . Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes donepezil hcl form – i. Therapeutic segment: CNS. Contact us for more information.

Neuland Laboratories Limited offers a wide range of API's which includes Edaravone. Therapeutic segment:  Neurology. Contact us for more information.

Neuland Laboratories Limited has entered into a development collaboration with LIR Life Sciences Corp to advance a novel transdermal GLP-1/GIP therapy platform for obesity. The partnership highlights Neuland’s growing expertise in peptide development and manufacturing, supporting the development of innovative cell-penetrating peptide (CPP) technologies designed to enable non-invasive drug delivery.

Neuland Laboratories is expanding its process development capabilities with a new $20 million (₹189 crore) dedicated Process Development Centre in Hyderabad. Designed exclusively for process development and integrated scale-up activities, the 135,000 sq. ft. facility will house over 500 scientists and strengthen Neuland’s ability to accelerate development timelines, improve scale-up readiness, and support complex API and peptide programs from early development through commercialization.